Form 4 for ELOX Eloxx Pharmaceuticals, Inc.
Accepted 2021-12-01 00:00:00 ET · period of report 2021-11-29 · accession 0001415889-21-005600 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-01 | 2021-11-29 | ELOX | Geffken Daniel E. | INTERIM CFO | P - Purchase | $0.72 | +50.0K | 50.0K | New | +$36.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-29 | P | A | 50,000 | $0.72 | 50,000 | D | — | — | (F1) Price represents the average purchase price per share. |